期刊文献+

伊布利特转复房扑房颤的临床观察

下载PDF
导出
摘要 目的观察伊布利特在转复心房颤动、心房扑动的疗效和安全性,总结转复过程中的护理体会。方法选择32例入选的无禁忌证持续时间小于90d心房颤动、心房扑动的患者,静推伊布利特,密切观察转复过程中的心电图、生命体征,观察转复过程中的不良反应。结果持续90d内,不同病程的心房颤动、心房扑动转复成功率差别不大。发生短阵室性心动过速2例。结论对于心房颤动、心房扑动患者,伊布利特是相对安全有效的转复药物之一。
作者 刘红俊 高兵
出处 《中西医结合心脑血管病杂志》 2010年第7期870-871,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献3

二级参考文献13

  • 1张海澄,郭继鸿,方全,郑亚安,孙跃民,朱文青,万征,郭静萱,葛均波,韩少梅.静脉注射伊布利特与普罗帕酮转复心房颤动和扑动的多中心研究[J].中华医学杂志,2005,85(12):798-801. 被引量:43
  • 2Li Y,Tian L,Huang Y,et al.Pharmacokinetic and pharmacodynamic properties of a single intravenous dose of ibutilide fumarate:a phase I,randomized,open-label,increasing-dose study in healthy Chinese men[J].Clin Ther,2007,29(9):1957-1960.
  • 3Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 g-uidelines for the management of patients with atrial fibrillation:a report of the american college of cardiology/american heart association task force on practice guideline and the european society of cardiology committee for practice guideline[J].Circulation,2006,114(7):700-752.
  • 4Miller MR, McNamara RL, Segal JB,et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a Meta analysis of clinical trials. J Fam Pract,2000,49:1033-1046.
  • 5Cropp Js, Antal EG, Talbert RL,et al. Ibutilide: a new class Ⅲ antiarrhythmic agent. Parmarcotherapy, 1997,17:1-9.
  • 6Lych JR, Baskin EP, Nutt EM, et al, Comparision of binding to rapidly activating delayed rectifier K channel, Ikr and effects on myocardial refractoriness for class Ⅲ antiarrythmic agents. J Cardiovasc Pharmacol, 1995,25:336-340.
  • 7Naccarelli GV, Lee KS, Gibson JK, et al. Electrophysiology and pharmacology of Ibutilide. Am J Cardiol,1996,78(8A): 12-16.
  • 8Baskin EP , Lynch JJ Jr. Differential atrial versus ventricular activities of class Ⅲ potassium channel blockers. Pharmacol Exp Ther, 1998,285:135-142.
  • 9Ellenbogen KA, Stambler BS, Wood MA, et al . Efficacy of intravenous Ibutilide for rapid termination of atrial fibrillation and atril flutter: a dose-response study. J Am Coll Cardiol, 1996, 28: 130-136.
  • 10Gowdw RM, Punukollu G, Khan LA, et al. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety. Am J Ther, 2003,10: 259-263.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部